INAMER_210925_141
Existing comment:
Vaccine Deaths (VAERS)
[ Vaccine Adverse Event Reporting System ]

From https://vaers.hhs.gov/data.html
VAERS Data

VAERS data is accessible by downloading raw data in comma-separated value (CSV) files for import into a database, spreadsheet, or text editing program, or by using the CDC WONDER online search tool. Information provided to VAERS which identifies a person who received the vaccine or vaccines will not be made available to the public. De-identified VAERS data are available 4-6 weeks after the report is received. VAERS data change as new reports are received, so your results may change if you repeat the same search at a later date. To learn more about interpreting data see Guide to Interpreting VAERS Data.
Disclaimer

VAERS accepts reports of adverse events and reactions that occur following vaccination. Healthcare providers, vaccine manufacturers, and the public can submit reports to the system. While very important in monitoring vaccine safety, VAERS reports alone cannot be used to determine if a vaccine caused or contributed to an adverse event or illness. The reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. In large part, reports to VAERS are voluntary, which means they are subject to biases. This creates specific limitations on how the data can be used scientifically. Data from VAERS reports should always be interpreted with these limitations in mind.

The strengths of VAERS are that it is national in scope and can quickly provide an early warning of a safety problem with a vaccine. As part of CDC and FDA's multi-system approach to post-licensure vaccine safety monitoring, VAERS is designed to rapidly detect unusual or unexpected patterns of adverse events, also known as "safety signals." If a safety signal is found in VAERS, further studies can be done in safety systems such as the CDC's Vaccine Safety Datalink (VSD) or the Clinical Immunization Safety Assessment (CISA) project. These systems do not have the same scientific limitations as VAERS, and can better assess health risks and possible connections between adverse events and a vaccine.

Key considerations and limitations of VAERS data:

* Vaccine providers are encouraged to report any clinically significant health problem following vaccination to VAERS, whether or not they believe the vaccine was the cause.
* Reports may include incomplete, inaccurate, coincidental and unverified information.
* The number of reports alone cannot be interpreted or used to reach conclusions about the existence, severity, frequency, or rates of problems associated with vaccines.
* VAERS data is limited to vaccine adverse event reports received between 1990 and the most recent date for which data are available.
* VAERS data do not represent all known safety information for a vaccine and should be interpreted in the context of other scientific information.

From https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html

Reports of death after COVID-19 vaccination are rare. More than 459 million doses of COVID-19 vaccines were administered in the United States from December 14, 2020, through November 29, 2021. During this time, VAERS received 10,128 reports of death (0.0022%) among people who received a COVID-19 vaccine. FDA requires healthcare providers to report any death after COVID-19 vaccination to VAERS, even if it's unclear whether the vaccine was the cause. Reports of adverse events to VAERS following vaccination, including deaths, do not necessarily mean that a vaccine caused a health problem. CDC clinicians review reports of death to VAERS including death certificates, autopsy, and medical records. A review of reports indicates a causal relationship between the J&J/Janssen COVID-19 Vaccine and TTS, a rare and serious adverse event -- that causes blood clots with low platelets -- which has caused or directly contributed to six confirmed deathsexternal icon.
Proposed user comment: